Navigation Links
Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia
Date:12/8/2009

NEW ORLEANS, Dec. 8 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL). The data were presented in an oral presentation(1) at the 51st Annual Meeting of the American Society of Hematology (ASH) and were selected by the Society for inclusion in its "Best of ASH" session. Blinatumomab is a CD19-specific, T cell-engaging BiTE antibody designed to direct a patient's own T cells against cancer cells inducing a self-destruction process in cancer cells.

A total of 21 patients were treated in a phase 2 clinical trial performed in collaboration with the German Multicenter Study Group on Adult Lymphoblastic Leukemia (GMALL). After having received extensive chemotherapy, all patients had ALL malignant cells persisting in their bone marrow, a disease state referred to as minimal residual disease (MRD). The primary endpoint of the clinical trial was the elimination of these cancer cells to an undetectable level in at least 22% of patients. 80% of the evaluable patients (16 of 20 patients) achieved the primary endpoint, all of them already during the first treatment cycle. The responses appear to be durable, with patients free of relapse for currently up to 15 months.

Overall, blinatumomab was well tolerated. The most common adverse events included lymphopenia, leucopenia, pyrexia and hypoimmunoglobulinemia. One patient had to discontinue treatment due to a fully reversible neurological adverse event, and was therefore not evaluable for response assessment.

"Today, patients with MRD-positive ALL after first line therapy have a very high likeli
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER
2. Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
3. Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
4. GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
5. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
6. Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
7. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
8. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
9. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
10. White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
11. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... HILL, N.C. , Nov. 21, 2014 /PRNewswire/ ... healthcare system. Undoubtedly, the growing influence of patients ... spend for marketing interactions. Now, more than ever, ... retain patients for medical products is essential. ... firm, Best Practices, LLC, benchmarked companies spent about ...
(Date:11/21/2014)...  The University of Maryland,s A. James Clark School ... the new A. James Clark Hall at the University ... transformative new engineering and biomedical technologies to accelerate advancements ... a.m. on November 21 at the site of the ... to the Jeong H. Kim Engineering Building, the event ...
(Date:11/21/2014)...  Tandem Diabetes Care ® , Inc. (NASDAQ: ... and manufacturer of the t:slim ® Insulin ... non-profit dedicated to improving diabetes therapy management by ... diabetes data accessibility. This partnership will enable users ... development, to download and access data from their ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... Syngenta lawsuits are now being investigated by ... agribusinesses that have allegedly incurred significant financial damages due ... Agrisure Duracade, genetically modified (GMO) corn seed products ... China. According to a report from Bloomberg News, Syngenta’s ... imports. Because China is the third-largest American corn importer, ...
(Date:11/23/2014)... BambooFlooringChina.com , the world’s leader in bamboo flooring, has recently ... collection. Now, the business is announcing big discounts on these ... valid until Dec. 20, 2014. , The new click strand ... which makes it very easy to maintain. As one of ... make its website the best shopping platform for people who ...
(Date:11/22/2014)... 23, 2014 Every year AlignLife clinics ... AlignLife experience rapid growth in the Greenville, SC area ... opportunity. AlignLife of Simpsonville will be partnering ... their first annual Toy Drive. These six offices came ... support with this year's toy drive. With so many ...
(Date:11/22/2014)... Cancer researchers in New York and ... communication tunnels and the growth and spread of mesothelioma. ... on the Surviving Mesothelioma website. , Doctors at ... Minnesota have just released their study on tunneling nanotubes ... cells. They found that mesothelioma cells contain ...
Breaking Medicine News(10 mins):Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2
... received a three-year, $6 million grant from the Bill ... for strengthening national public health institutes (NPHIs) globally. ... to the International Association of National Public Health Institutes ... increased capacity at NPHIs in 10 low-resource countries. ...
... One in 13 teenage girls, aged 14 to 20, reported ... to have been exposed to pornography and childhood sexual abuse ... a Boston University School of Public Health (BUSPH) researcher. In ... Bulletin of the New York Academy of Medicine, Emily ...
... News) -- Infants born to mothers who use inhaled glucocorticoids ... pregnancy may be at risk for endocrine and metabolic disorders, ... 65,000 mother-child pairs from the Danish National Birth Cohort who ... women in the study, about 61,000 (94 percent) had no ...
... FRIDAY, Dec. 16 (HealthDay News) -- Playing football may ... to a small new study. Researchers from the ... case studies of teen football players who suffered a ... likelihood of a stroke. These factors included: an ...
... researchers at Cold Spring Harbor Laboratory (CSHL) have carried ... in the DNA of a patient with mast cell ... leukemia (AML) with a very poor prognosis. ... mutations that could directly influence patient response to currently ...
... , THURSDAY, Dec. 15 (HealthDay News) -- Americans, heart health ... from the American Heart Association. And it,s largely because ... the past three or so decades, women have upped their ... with carbohydrates and sugar-sweetened beverages both major sources of unneeded ...
Cached Medicine News:Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 2Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 3Health News:Emory and US CDC partner to continue building global public health network with $6 million grant 4Health News:Group sex among adolescents a public health concern, new study says 2Health News:Group sex among adolescents a public health concern, new study says 3Health News:Asthma Drugs in Pregnancy Might Pose Risk for Kids 2Health News:Study Looks at Stroke Risks in Teen Football Players 2Health News:First comprehensive DNA study of mast cell leukemia uncovers clues that could improve therapy 2Health News:First comprehensive DNA study of mast cell leukemia uncovers clues that could improve therapy 3Health News:Poor Lifestyles Harming U.S. Heart Health: Report 2
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... Family offers fast temperature control, exact block ... Personal cards enable safe program storage as ... individual protocols between different Mastercyclers. All models ... come with a two-year warranty. The ...
... with unique High Temperature Range ... available heating and cooling rates ... Pressure Lid for automated sealing ... motorized lid for automated opening/closing ...
... a graphical touch screen display which enables ... "touch of a screen." Features & ... Screen, Graphical Display, Memory Cards, Gradient Calculator, ... Intuitive Programmin, Free Instrument Software Upgrade. ...
Medicine Products: